Animal Drugs @FDAThere are eight sections in the publication. The first lists approved drug products; subsections being sorted by tradename and then by NADA number. The second section lists active ingredients and each approved product containing that active ingredient. The third section lists patent information as provided by the sponsors of approved animal drug products. Section four lists exclusivity periods granted for new uses or claims approved subsequent to enactment of GADPTRA. Section five lists any approved products that are currently the subject of a Notice of Hearing and thus may not be used as a basis of an ANADA. Section six lists animal drug products whose approval has been voluntarily withdrawn by their sponsors since GADPTRA was enacted.Section seven lists the actions on ANADA suitability petitions that have been received by the FDA since the enactment of GADPTRA. Section eight is reserved for monthly updates.
The WAHID Interface provides access to all data held within OIE's new World Animal Health Information System (WAHIS).
A comprehensive range of information is available from: -Immediate notifications and follow-up reports submitted by Member Countries in response to exceptional disease events occurring in these countries as well as follow-up reports about these events, -Six-monthly reports describing the OIE-listed disease situations in each country -Annual reports providing further background information on animal health, on laboratory and vaccine production facilities, etc. To start, select one of the headings on the left. You can then explore available information: -by country (or group of countries), -by disease, -focusing on control measures, or -comparing the animal health situation between two countries.